Off-Label Use Of Transmucosal Fentanyl Creates Ethical, Practical Dilemma For US FDA
Advisory committee panelists divided on whether to modify REMS for TIRF products to reduce their wide-ranging off-label use.
Advisory committee panelists divided on whether to modify REMS for TIRF products to reduce their wide-ranging off-label use.